Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thandavarayan Ramamurthy is active.

Publication


Featured researches published by Thandavarayan Ramamurthy.


The Lancet | 2013

Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study

Karen L. Kotloff; James P. Nataro; William C. Blackwelder; Dilruba Nasrin; Tamer H. Farag; Sandra Panchalingam; Yukun Wu; Samba O. Sow; Dipika Sur; Robert F. Breiman; Abu S. G. Faruque; Anita K. M. Zaidi; Debasish Saha; Pedro L. Alonso; Boubou Tamboura; Doh Sanogo; Uma Onwuchekwa; Byomkesh Manna; Thandavarayan Ramamurthy; Suman Kanungo; John B. Ochieng; Richard Omore; Joseph Oundo; Anowar Hossain; Sumon Kumar Das; Shahnawaz Ahmed; Shahida Qureshi; Farheen Quadri; Richard A. Adegbola; Martin Antonio

BACKGROUND Diarrhoeal diseases cause illness and death among children younger than 5 years in low-income countries. We designed the Global Enteric Multicenter Study (GEMS) to identify the aetiology and population-based burden of paediatric diarrhoeal disease in sub-Saharan Africa and south Asia. METHODS The GEMS is a 3-year, prospective, age-stratified, matched case-control study of moderate-to-severe diarrhoea in children aged 0-59 months residing in censused populations at four sites in Africa and three in Asia. We recruited children with moderate-to-severe diarrhoea seeking care at health centres along with one to three randomly selected matched community control children without diarrhoea. From patients with moderate-to-severe diarrhoea and controls, we obtained clinical and epidemiological data, anthropometric measurements, and a faecal sample to identify enteropathogens at enrolment; one follow-up home visit was made about 60 days later to ascertain vital status, clinical outcome, and interval growth. FINDINGS We enrolled 9439 children with moderate-to-severe diarrhoea and 13,129 control children without diarrhoea. By analysing adjusted population attributable fractions, most attributable cases of moderate-to-severe diarrhoea were due to four pathogens: rotavirus, Cryptosporidium, enterotoxigenic Escherichia coli producing heat-stable toxin (ST-ETEC; with or without co-expression of heat-labile enterotoxin), and Shigella. Other pathogens were important in selected sites (eg, Aeromonas, Vibrio cholerae O1, Campylobacter jejuni). Odds of dying during follow-up were 8·5-fold higher in patients with moderate-to-severe diarrhoea than in controls (odd ratio 8·5, 95% CI 5·8-12·5, p<0·0001); most deaths (167 [87·9%]) occurred during the first 2 years of life. Pathogens associated with increased risk of case death were ST-ETEC (hazard ratio [HR] 1·9; 0·99-3·5) and typical enteropathogenic E coli (HR 2·6; 1·6-4·1) in infants aged 0-11 months, and Cryptosporidium (HR 2·3; 1·3-4·3) in toddlers aged 12-23 months. INTERPRETATION Interventions targeting five pathogens (rotavirus, Shigella, ST-ETEC, Cryptosporidium, typical enteropathogenic E coli) can substantially reduce the burden of moderate-to-severe diarrhoea. New methods and accelerated implementation of existing interventions (rotavirus vaccine and zinc) are needed to prevent disease and improve outcomes. FUNDING The Bill & Melinda Gates Foundation.


Clinical Microbiology Reviews | 2007

Global Dissemination of Vibrio parahaemolyticus Serotype O3:K6 and Its Serovariants

G. Balakrish Nair; Thandavarayan Ramamurthy; Sujit K. Bhattacharya; Basabjit Dutta; Yoshifumi Takeda; David A. Sack

SUMMARY Vibrio parahaemolyticus is recognized as a cause of food-borne gastroenteritis, particularly in the Far East, where raw seafood consumption is high. An unusual increase in admissions of V. parahaemolyticus cases was observed at the Infectious Diseases Hospital in Calcutta, a city in the northeastern part of India, beginning February 1996. Analysis of the strains revealed that a unique serotype, O3:K6, not previously isolated during the surveillance in Calcutta accounted for 50 to 80% of the infections in the following months. After this report, O3:K6 isolates identical to those isolated in Calcutta were reported from food-borne outbreaks and from sporadic cases in Bangladesh, Chile, France, Japan, Korea, Laos, Mozambique, Peru, Russia, Spain, Taiwan, Thailand, and the United States. Other serotypes, such as O4:K68, O1:K25, and O1:KUT (untypeable), that had molecular characteristics identical to that of the O3:K6 serotype were subsequently documented. These serotypes appeared to have diverged from the O3:K6 serotype by alteration of the O:K antigens and were defined as “serovariants” of the O3:K6 isolate. O3:K6 and its serovariants have now spread into Asia, America, Africa, and Europe. This review traces the genesis, virulence features, molecular characteristics, serotype variants, environmental occurrence, and global spread of this unique clone of V. parahaemolyticus.


Nature | 2011

Evidence for several waves of global transmission in the seventh cholera pandemic

Ankur Mutreja; Dong Wook Kim; Nicholas R. Thomson; Thomas Richard Connor; Je Hee Lee; Samuel Kariuki; Nicholas J. Croucher; Seon Young Choi; Simon R. Harris; Michael Lebens; Swapan Kumar Niyogi; Eun Jin Kim; Thandavarayan Ramamurthy; Jongsik Chun; J. L. N. Wood; John D. Clemens; Cecil Czerkinsky; G. Balakrish Nair; Jan Holmgren; Julian Parkhill; Gordon Dougan

Vibrio cholerae is a globally important pathogen that is endemic in many areas of the world and causes 3–5 million reported cases of cholera every year. Historically, there have been seven acknowledged cholera pandemics; recent outbreaks in Zimbabwe and Haiti are included in the seventh and ongoing pandemic. Only isolates in serogroup O1 (consisting of two biotypes known as ‘classical’ and ‘El Tor’) and the derivative O139 (refs 2, 3) can cause epidemic cholera. It is believed that the first six cholera pandemics were caused by the classical biotype, but El Tor has subsequently spread globally and replaced the classical biotype in the current pandemic. Detailed molecular epidemiological mapping of cholera has been compromised by a reliance on sub-genomic regions such as mobile elements to infer relationships, making El Tor isolates associated with the seventh pandemic seem superficially diverse. To understand the underlying phylogeny of the lineage responsible for the current pandemic, we identified high-resolution markers (single nucleotide polymorphisms; SNPs) in 154 whole-genome sequences of globally and temporally representative V. cholerae isolates. Using this phylogeny, we show here that the seventh pandemic has spread from the Bay of Bengal in at least three independent but overlapping waves with a common ancestor in the 1950s, and identify several transcontinental transmission events. Additionally, we show how the acquisition of the SXT family of antibiotic resistance elements has shaped pandemic spread, and show that this family was first acquired at least ten years before its discovery in V. cholerae.


The Lancet | 2016

Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study

Jie Liu; James A. Platts-Mills; Jane Juma; Furqan Kabir; Joseph Nkeze; Catherine Okoi; Darwin J. Operario; Jashim Uddin; Shahnawaz Ahmed; Pedro L. Alonso; Martin Antonio; Stephen M. Becker; William C. Blackwelder; Robert F. Breiman; Abu S. G. Faruque; Barry S. Fields; Jean Gratz; Rashidul Haque; Anowar Hossain; M. Jahangir Hossain; Sheikh Jarju; Farah Naz Qamar; Najeeha Talat Iqbal; Brenda Kwambana; Inacio Mandomando; Timothy L. McMurry; Caroline Ochieng; John B. Ochieng; Melvin Ochieng; Clayton O. Onyango

BACKGROUND Diarrhoea is the second leading cause of mortality in children worldwide, but establishing the cause can be complicated by diverse diagnostic approaches and varying test characteristics. We used quantitative molecular diagnostic methods to reassess causes of diarrhoea in the Global Enteric Multicenter Study (GEMS). METHODS GEMS was a study of moderate to severe diarrhoea in children younger than 5 years in Africa and Asia. We used quantitative real-time PCR (qPCR) to test for 32 enteropathogens in stool samples from cases and matched asymptomatic controls from GEMS, and compared pathogen-specific attributable incidences with those found with the original GEMS microbiological methods, including culture, EIA, and reverse-transcriptase PCR. We calculated revised pathogen-specific burdens of disease and assessed causes in individual children. FINDINGS We analysed 5304 sample pairs. For most pathogens, incidence was greater with qPCR than with the original methods, particularly for adenovirus 40/41 (around five times), Shigella spp or enteroinvasive Escherichia coli (EIEC) and Campylobactor jejuni o C coli (around two times), and heat-stable enterotoxin-producing E coli ([ST-ETEC] around 1·5 times). The six most attributable pathogens became, in descending order, Shigella spp, rotavirus, adenovirus 40/41, ST-ETEC, Cryptosporidium spp, and Campylobacter spp. Pathogen-attributable diarrhoeal burden was 89·3% (95% CI 83·2-96·0) at the population level, compared with 51·5% (48·0-55·0) in the original GEMS analysis. The top six pathogens accounted for 77·8% (74·6-80·9) of all attributable diarrhoea. With use of model-derived quantitative cutoffs to assess individual diarrhoeal cases, 2254 (42·5%) of 5304 cases had one diarrhoea-associated pathogen detected and 2063 (38·9%) had two or more, with Shigella spp and rotavirus being the pathogens most strongly associated with diarrhoea in children with mixed infections. INTERPRETATION A quantitative molecular diagnostic approach improved population-level and case-level characterisation of the causes of diarrhoea and indicated a high burden of disease associated with six pathogens, for which targeted treatment should be prioritised. FUNDING Bill & Melinda Gates Foundation.


Antimicrobial Agents and Chemotherapy | 2002

Occurrence of Antibiotic Resistance Gene Cassettes aac(6′)-Ib, dfrA5, dfrA12, and ereA2 in Class I Integrons in Non-O1, Non-O139 Vibrio cholerae Strains in India

M. Thungapathra; Amita; Kislay K. Sinha; Saumya Ray Chaudhuri; Pallavi Garg; Thandavarayan Ramamurthy; G. B. Nair; Amit Ghosh

ABSTRACT Molecular mechanisms of multidrug resistance in Vibrio cholerae belonging to non-O1, non-O139 serogroups isolated during 1997 to 1998 in Calcutta, India, were investigated. Out of the 94 strains examined, 22 strains were found to have class I integrons. The gene cassettes identified were dfrA1, dfrA15, dfrA5, and dfrA12 for trimethoprim; aac(6′)-Ib for amikacin and tobramycin; aadA1 and aadA2 for streptomycin and spectinomycin; and ereA2 for erythromycin resistance. To our knowledge, this is the first report of the presence of dfrA5, dfrA12, aac(6′)-Ib, and ereA2 cassettes in class I integrons of V. cholerae. Forty-three of 94 strains also had plasmids, and out of these, 14 contained both class I integrons and plasmids. Pulsed-field gel electrophoresis followed by Southern hybridization revealed that in the 14 plasmid-bearing strains, class I integrons resided either on chromosomes, on plasmids, or on both. Our results indicated that besides class I integrons and plasmids, a conjugative transposon element, SXT, possibly contributed to the multiple antibiotic resistance.


Clinical Infectious Diseases | 2014

Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development

Sofie Livio; Nancy A. Strockbine; Sandra Panchalingam; Sharon M. Tennant; Eileen M. Barry; Mark E. Marohn; Martin Antonio; Anowar Hossain; Inacio Mandomando; John B. Ochieng; Joseph Oundo; Shahida Qureshi; Thandavarayan Ramamurthy; Boubou Tamboura; Richard A. Adegbola; Mohammed Jahangir Hossain; Debasish Saha; Sunil Sen; Abu Syed Golam Faruque; Pedro L. Alonso; Robert F. Breiman; Anita K. M. Zaidi; Dipika Sur; Samba O. Sow; Lynette Y. Berkeley; Ciara E. O'Reilly; Eric D. Mintz; Kousick Biswas; Dani Cohen; Tamer H. Farag

Shigella case isolates from the Global Enteric Multicenter Study were serotyped to guide vaccine development. A quadrivalent vaccine that includes O antigens from S. sonnei, S. flexneri 2a, S. flexneri 3a, and S. flexneri 6 should provide broad protection.


Frontiers in Public Health | 2014

Current Perspectives on Viable but Non-Culturable (VBNC) Pathogenic Bacteria

Thandavarayan Ramamurthy; Ghosh A; Gururaja P. Pazhani; Sumio Shinoda

Under stress conditions, many species of bacteria enter into starvation mode of metabolism or a physiologically viable but non-culturable (VBNC) state. Several human pathogenic bacteria have been reported to enter into the VBNC state under these conditions. The pathogenic VBNC bacteria cannot be grown using conventional culture media, although they continue to retain their viability and express their virulence. Though there have been debates on the VBNC concept in the past, several molecular studies have shown that not only can the VBNC state be induced under in vitro conditions but also that resuscitation from this state is possible under appropriate conditions. The most notable advance in resuscitating VBNC bacteria is the discovery of resuscitation-promoting factor (Rpf), which is a bacterial cytokines found in both Gram-positive and Gram-negative organisms. VBNC state is a survival strategy adopted by the bacteria, which has important implication in several fields, including environmental monitoring, food technology, and infectious disease management; and hence it is important to investigate the association of bacterial pathogens under VBNC state and the water/foodborne outbreaks. In this review, we describe various aspects of VBNC bacteria, which include their proteomic and genetic profiles under the VBNC state, conditions of resuscitation, methods of detection, antibiotic resistance, and observations on Rpf.


Clinical Infectious Diseases | 2012

Diagnostic Microbiologic Methods in the GEMS-1 Case/Control Study

Sandra Panchalingam; Martin Antonio; Anowar Hossain; Inacio Mandomando; Ben Ochieng; Joseph Oundo; Thandavarayan Ramamurthy; Boubou Tamboura; Anita K. M. Zaidi; William A. Petri; Eric R. Houpt; Patrick Murray; Valeria Prado; Roberto Vidal; Duncan Steele; Nancy A. Strockbine; Philippe J. Sansonetti; Roger I. Glass; Roy M. Robins-Browne; Marija Tauschek; A. M. Svennerholm; Karen L. Kotloff; Myron M. Levine; James P. Nataro

To understand the etiology of moderate-to-severe diarrhea among children in high mortality areas of sub-Saharan Africa and South Asia, we performed a comprehensive case/control study of children aged <5 years at 7 sites. Each site employed an identical case/control study design and each utilized a uniform comprehensive set of microbiological assays to identify the likely bacterial, viral and protozoal etiologies. The selected assays effected a balanced consideration of cost, robustness and performance, and all assays were performed at the study sites. Identification of bacterial pathogens employed streamlined conventional bacteriologic biochemical and serological algorithms. Diarrheagenic Escherichia coli were identified by application of a multiplex polymerase chain reaction assay for enterotoxigenic, enteroaggregative, and enteropathogenic E. coli. Rotavirus, adenovirus, Entamoeba histolytica, Giardia enterica, and Cryptosporidium species were detected by commercially available enzyme immunoassays on stool samples. Samples positive for adenovirus were further evaluated for adenovirus serotypes 40 and 41. We developed a novel multiplex assay to detect norovirus (types 1 and 2), astrovirus, and sapovirus. The portfolio of diagnostic assays used in the GEMS study can be broadly applied in developing countries seeking robust cost-effective methods for enteric pathogen detection.


Cellular Microbiology | 2008

Bacterial exotoxins downregulate cathelicidin (hCAP‐18/LL‐37) and human β‐defensin 1 (HBD‐1) expression in the intestinal epithelial cells

Krishnendu Chakraborty; Shubhamoy Ghosh; Hemanta Koley; Asish K. Mukhopadhyay; Thandavarayan Ramamurthy; Dhira Rani Saha; Debashis Mukhopadhyay; Swasti Roychowdhury; Takashi Hamabata; Yoshifumi Takeda; Santasabuj Das

Cathelicidin (hCAP‐18/LL‐37) and β‐defensin 1 (HBD‐1) are human antimicrobial peptides (AMPs) with high basal expression levels, which form the first line of host defence against infections over the epithelial surfaces. The antimicrobial functions owe to their direct microbicidal effects as well as the immunomodulatory role. Pathogenic microorganisms have developed multiple modalities including transcriptional repression to combat this arm of the host immune response. The precise mechanisms and the pathogen‐derived molecules responsible for transcriptional downregulation remain unknown. Here, we have shown that enteric pathogens suppress LL‐37 and HBD‐1 expression in the intestinal epithelial cells (IECs) with Vibrio cholerae and enterotoxigenic Escherichia coli (ETEC) exerting the most dramatic effects. Cholera toxin (CT) and labile toxin (LT), the major virulence proteins of V. cholerae and ETEC, respectively, are predominantly responsible for these effects, both in vitro and in vivo. CT transcriptionally downregulates the AMPs by activating several intracellular signalling pathways involving protein kinase A (PKA), ERK MAPKinase and Cox‐2 downstream of cAMP accumulation and inducible cAMP early repressor (ICER) may mediate this role of CT, at least in part. This is the first report to show transcriptional repression of the AMPs through the activation of cellular signal transduction pathways by well‐known virulence proteins of pathogenic microorganisms.


Emerging Infectious Diseases | 2009

Classical ctxB in Vibrio cholerae O1, Kolkata, India

Amit Raychoudhuri; Tapas Patra; Kausik Ghosh; Thandavarayan Ramamurthy; Ranjan K. Nandy; Yoshifumi Takeda; G. Balakrish Nair; Asish K. Mukhopadhyay

To the Editor: Among the 206 serogroups of Vibrio cholerae, O1 and O139 are associated with epidemic cholera. Serogroup O1 is classified into 2 biotypes, classical and El Tor. Conventionally, the 2 biotypes can be differentiated on the basis of a set of phenotypic traits. Comparative genomic analysis has shown variations in different genes between these biotypes (1). Cholera toxin (CT), the major toxin responsible for the disease cholera, has 2 epitypes or immunologic forms, CT1 and CT2 (2). Another classification recognizes 3 genotypes on the basis of the ctxB gene sequence variation (3). In the past few years, a new emerging form of V. cholerae O1, which possesses traits of both classical and El Tor biotypes, has been isolated in Bangladesh (4,5), Mozambique (6), Vietnam, Hong Kong, Japan, and Zambia (7). These strains were variously labeled as Matlab variants, hybrids, or altered El Tor strains. Our study analyzed, in chronological order, strains of V. cholerae O1 that were isolated over 17 years (1989–2005). We used strains isolated during diarrhea surveillance conducted at the Infectious Diseases Hospital, Kolkata (Calcutta), to determine precisely when the hybrid strains appeared in this region. A total of 171 strains of V. cholerae O1, which were selected to cover different months of each year, were included in this study, along with 2 reference strains for classical and El Tor biotypes. The V. cholerae strains were confirmed serologically by slide agglutination using a specific polyvalent antiserum to V. cholerae O1. We focused on the ctxB gene. The strains were examined by mismatch amplification mutation assay (MAMA)–based PCR for detecting the ctxB allele; a common forward primer was used for 2 alleles, FW-Com (5′-ACTATCTTCAGCATATGCACATGG-3′); and 2 allele-specific primers, Re-cla (5′-cctggtacttctacttgaaacg-3′) and Re-elt (5′-CCTGGTACTTCTACTTGAAACA-3′), were used for classical and El Tor biotypes, respectively (8). Results of the MAMA-PCR are summarized in the Table. All of the 123 V. cholerae O1 strains from 1995 through 2005 yielded only the classical type of ctxB, which indicates that since 1995 the classical type has completely replaced the El Tor type ctxB (Table). To reconfirm our PCR-based results, we selected 25 representative strains for DNA sequencing of the ctxB gene. The deduced amino acid sequences were aligned with the CtxB sequences of reference strains N16961 (El Tor) and O395 (classical). The deduced amino acid sequences of all 25 strains were identical to those of the classical reference strain; histidine was at position 39 and threonine was at position 68. Thus, the results from DNA sequencing of the ctxB gene confirmed the MAMA-PCR results. Table Prevalence of different types of ctxB alleles among Vibrio cholerae O1 strains, Kolkata, India, 1989–2005 Our results highlight a noteworthy event in the evolution of recent V. cholerae strains. Analysis of type ctxB that had been circulating in Kolkata for 17 years (1989–2005) showed that in 1989 only the El Tor allele of ctxB was present. Our results further indicate that classical type ctxB emerged in 1990, although El Tor type ctxB was still present in almost equal numbers during that year. During 1991, a unique event took place when the classical type became predominant, along with strains having both classical and El Tor type ctxB. In 1994, isolation of strains with El Tor ctxB became rare, and the major ctxB allele was of the classical type. V. cholerae O1 strains from 1995 onward were found to carry classical type ctxB, which totally replaced the El Tor type ctxB allele. Replacement of El Tor type ctxB by the classical allele has been reported in Bangladesh since 2001 (5), but this event seems to have occurred earlier in Kolkata. Perhaps the new type of El Tor strains arose when V. cholerae strains with typical seventh pandemic El Tor genetic background were replaced with strains having the ctxB gene, possibly driven by selective pressure to survive and adapt better in host intestines. Considering the increase in the global prevalence of cholera (9), the origin and spread of these new variants of V. cholerae strains should be tracked in the population by genome analysis. Finally, this study has described a brief period from February 1991 through December 1992 when El Tor strains had CTX prophages of both classical and El Tor types (data not shown), along with the ctxB of both biotypes. Notably, this period coincided with an unprecedented event in the history of cholera—the genesis of the O139 serogroup. After this serogroup reemerged in 1996, it harbored 2 types of CTX prophages, namely, El Tor and Calcutta (10). Furthermore, these strains with ctxB of both biotypes might also have had a pivotal role behind the emergence of El Tor strains with classical ctxB. Further studies are warranted to determine whether any distinct relationship exists between these overlapping events.

Collaboration


Dive into the Thandavarayan Ramamurthy's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gururaja P. Pazhani

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Dipika Sur

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Shinji Yamasaki

Osaka Prefecture University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Asish K. Mukhopadhyay

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Byomkesh Manna

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge